Edition:
United Kingdom

Madenco Biosciences Announces Strategic Decision To Drop Consumer Health Products


Friday, 20 Jul 2018 

July 20 (Reuters) - Quest Pharmatech Inc ::MADENCO BIOSCIENCES ANNOUNCES STRATEGIC DECISION TO DROP CONSUMER HEALTH PRODUCTS AND FOCUS ON PHARMACEUTICAL PRODUCT DEVELOPMENT.MADENCO BIOSCIENCES SAYS WILL NO LONGER PROMOTE BELLUS SKIN LINE OF SKIN CARE PRODUCTS.MADENCO BIOSCIENCES SAYS DETERMINED THAT CONSUMER HEALTH PRODUCTS ARE NOT PROVIDING RETURNS ON CAPITAL THAT CO EXPECTS.MADENCO BIOSCIENCES SAYS ALSO NEGOTIATED A RETURN OF ITS PRINCIPAL INVESTMENT IN NATURAL RF LIFE SCIENCES.MADENCO BIOSCIENCES - CONTINUES TO HAVE ABOUT 20% EQUITY INTEREST IN SOUTH KOREA BASED BIOCELTRAN. 

Company Quote

0.16
 --
8 Aug 2018